Dementia Systems Biology Group

🚨Great PhD opportunity (deadline 20 May!) to work on white matter molecular dysfunction in dementia with me @saobettencourt, @JBar_UK & @tammarynlashley at @UCLIoN. See further details and how to apply here: ucl.ac.uk/ion/building-y…

Please check out our latest work @dementia_sysbio, where we used whole blood genome-wide DNA methylation data as a surrogate for 14 modifiable and non-modifiable factors in assessing #dementia risk. @ZonMw @alzheimernl @MaastrichtU @ExeterMed @EPND #ouderen #EMIF #PPMI #ADNI

🚨Our Hot Topic Perspective piece with @NikosDaskalakis for @npp_journal summarizing the recent updates on #PTSD genomic studies is out! Groundbreaking studies from @MattGirgenti, @CChatzinakos, @DrCriCru, @RachelYehuda, @kristenbrennand and others are advancing the field!🧠

Join our next @DEMONNetworkUK Genetics and Omics meeting on THURSDAY 13th July at 2.30 PM (UK Time). Delighted to have Valentin Laroche as guest speaker - “Methylomic-based molecular subtyping of sporadic #Alzheimer's disease”. Join network for more info (demondementia.com/join/)

Jarno Koetsier will be sharing findings from our latest research at @dementia_sysbio. Join us to learn about our DNA methylation-based prediction of midlife dementia risk. Don't miss this presentation at the @DEMONNetworkUK Biomarkers WG! #dementia #omics

📢Join @DEMONNetworkUK Biomarkers WG⬇️ Wednesday 5th July @10am BST. We are excited to host Jarno Koetsier, PhD candidate at Maastricht University, School for Mental Health and Neurosciences @dementia_sysbio discussing “DNA methylation-based prediction of midlife dementia risk”

Deeply grateful to the Michael J. Fox Foundation @MichaelJFoxOrg for funding our RFA Proposal @dementia_sysbio @MaastrichtU on "Genomic and epigenomic approaches to molecular subtyping of Lewy body diseases". Thanks to @katielunnon @LassePihlstrm @Josiaharvey @Rachel Cavill